In conclusion, we demonstrate that Aurora-A inhibition by the Aurora kinase inhibitor, PHA680632, in association with radiation leads to an additive effect in cancer cells, especially in p53-deficient cells but does not act as a radiosensitiser in vitro or in vivo. The gene discussed is TP53; the disease is cancer.